2.8005
price up icon11.57%   0.2905
after-market After Hours: 2.64 -0.1605 -5.73%
loading

Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
5.75%
0.9669
1.0259 1.0242 1.67 1.3701
Interest Income/Expense
29.17%
0.00719
0.0101 0.000279 0.00195 0.00386
Operating Income/Loss
5.75%
-0.9669
-1.0259 -1.0242 -1.67 -1.3701
Income/Loss From Continuing Operations Before Tax
5.90%
-0.9713
-1.0323 -1.0188 -1.6684 -1.3677
Income/Loss From Continuing Operations After Tax
5.90%
-0.9713
-1.0323 -1.0188 -1.6684 -1.3677
Net Income/Loss
5.90%
-0.9713
-1.0323 -1.0188 -1.6684 -1.3677
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,902%
2.2493
0.1124 2.0749 1.666 16.65
Diluted Average Shares
1,902%
2.2493
0.1124 2.0749 1.666 -0.000477
Basic Earnings Per Share
4.88%
-0.43
-0.41 -0.49 -1.00 -0.08
Diluted Earnings Per Share
4.88%
-0.43
-0.41 -0.49 -1.00 -0.82
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):